|
Market Closed -
Nasdaq Stockholm
21:00:00 28/10/2026 +04
|
5-day change | 1st Jan Change | ||
| 1.660 SEK | 0.00% |
|
-1.78% | -65.45% |
| 10-15 | Two Sigma Investments becomes a new public short seller in Oncopeptides | FW |
| 10-14 | Mixed close on Stockholm exchange, SEB fell on higher capital requirements | FW |
| Market Cap | 656M 66.16M 59.36M 54.88M 49.7M 92.86M 6.3B 93.98M 261M 3.3B 248M 243M 10.47B | P/E 2026 * |
-3.49x | P/E 2027 * | -7.38x |
|---|---|---|---|---|---|
| Enterprise Value | 710M 71.61M 64.25M 59.4M 53.79M 101M 6.82B 102M 283M 3.57B 269M 263M 11.33B | EV / Sales 2026 * |
5.51x | EV / Sales 2027 * | 2.88x |
| Free-Float |
96.15% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq Stockholm
| ONCO | Delayed | |
CBOE
| ONCOs | Real-time | |
|
Deutsche Boerse AG
| OND | Delayed | |
|
London S.E.
| 0RN4 | Delayed | |
|
CBOE
| 0RN4 | Real-time | |
|
Börse Stuttgart
| OND | Delayed | |
|
Boerse Muenchen
| OND | Real-time |
Last Transcript: Oncopeptides AB
| 1 week | -1.78% | ||
| Current month | -24.06% | ||
| 1 month | -30.54% | ||
| 3 months | +3.30% | ||
| 6 months | +20.99% | ||
| Current year | -65.45% |
| 1 week | 1.62 |  | 1.75 |
| 1 month | 1.62 | | 3.18 |
| Current year | 1.26 | | 4.91 |
| 1 year | 1.26 | | 6.14 |
| 3 years | 1.1 | | 9.4 |
| 5 years | 1.1 | | 50.84 |
| 10 years | 1.1 | | 215 |
| Manager | Title | Age | Since |
|---|---|---|---|
Sofia Heigis
CEO | Chief Executive Officer | 46 | 07/08/2023 |
| Director of Finance/CFO | 52 | 13/11/2023 | |
Stefan Norin
CTO | Chief Tech/Sci/R&D Officer | 54 | 01/09/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 65 | 01/01/2012 | |
| Director/Board Member | 63 | 01/02/2017 | |
Per Wold-Olsen
CHM | Chairman | 78 | 17/05/2018 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 20/03/26 | Free | Chief Technology Officer | 3,000 | 0.0008% | ||
| 18/03/26 | Buy | 14,631 | 0.0038% | |||
| 17/03/26 | Free | Investor Relations Manager | 66 | 0.0000% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | -1.78% | -67.77% | -76.20% | 66.16M | |
| +0.65% | -3.36% | +36.98% | +60.50% | 64.14B | |
| +1.76% | +1.27% | +11.82% | +81.21% | 55.53B | |
| -0.94% | +0.99% | +10.45% | +100.19% | 53.03B | |
| +2.76% | +0.87% | +27.92% | +55.07% | 45.99B | |
| +2.00% | -3.39% | +17.83% | +119.04% | 42.45B | |
| +1.34% | -2.86% | +224.43% | +914.08% | 40.45B | |
| +0.64% | -3.95% | +11.15% | +45.57% | 32.25B | |
| +29.06% | +47.63% | +107.12% | +92.73% | 34.47B | |
| -2.29% | 0.00% | +23.73% | -10.38% | 24.23B | |
| Average | +3.50% | +3.50% | +40.37% | +138.18% | 39.26B | |
| Weighted average by Cap. | +3.37% | +3.49% | +49.22% | +159.63% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 129M 13M 11.67M 10.79M 9.77M 18.25M 1.24B 18.47M 51.37M 648M 48.8M 47.77M 2.06B | 252M 25.38M 22.77M 21.05M 19.07M 35.62M 2.42B 36.06M 100M 1.26B 95.25M 93.24M 4.02B |
| Net income | -167M -16.79M -15.07M -13.93M -12.61M -23.57M -1.6B -23.85M -66.33M -837M -63.01M -61.68M -2.66B | -62.47M -6.3M -5.65M -5.22M -4.73M -8.84M -600M -8.95M -24.88M -314M -23.64M -23.14M -997M |
| Net Debt | 54M 5.44M 4.89M 4.52M 4.09M 7.64M 519M 7.73M 21.51M 271M 20.43M 20M 861M | 68M 6.86M 6.15M 5.69M 5.15M 9.62M 653M 9.74M 27.08M 342M 25.73M 25.19M 1.08B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 28/10/26 | SEK 1.660 | 0.00% | 2,392,687 |
| 27/10/26 | SEK 1.660 | -0.60% | 2,994,287 |
| 26/10/26 | SEK 1.670 | -1.18% | 2,704,963 |
| 23/10/26 | SEK 1.690 | +1.93% | 3,811,505 |
| 22/10/26 | SEK 1.658 | -1.89% | 2,537,730 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ONCO Stock
Select your edition
All financial news and data tailored to specific country editions
